EUVIMEDEUVIMED entdecken
Open Access

Baseline Troponin Level and Cardiac Toxicity in HER2-positive Early Breast Cancer Patients Receiving Trastuzumab

Maria Laura Canale, Giancarlo Casolo, Sara Donati, Irma Bisceglia, Cheti Puccetti, Domenico Amoroso, Elio Venturini, Nicola Maurea, Fabio Maria Turazza, Andrea Camerini

In Vivo · 2023

DOI: 10.21873/invivo.13311 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vivo, 2023. Verfasst von Maria Laura Canale und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Division, Azienda USL Toscana Nord-Ovest, Versilia Hospital, Lido di Camaiore, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Heart Failure. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHeart FailureHumansMiddle AgedFemaleTrastuzumabCardiotoxicityTroponinStroke VolumeVentricular Function, LeftAnthracyclinesTroponin TErb-b2 Receptor Tyrosine Kinases

Stichwörter der Autor:innen

Cardio-oncologyanthracyclinescardiac biomarkercardiac toxicitytrastuzumabtroponin

Substanzen

TrastuzumabTroponinAnthracyclinesTroponin TErb-b2 Receptor Tyrosine Kinases

Autor:innen und Institutionen

  • Cardiology Division, Azienda USL Toscana Nord-Ovest, Versilia Hospital, Lido di Camaiore, Italy.
  • Medical Oncology, Azienda USL Toscana Nord-Ovest, Versilia Hospital, Lido di Camaiore, Italy.
  • Servizi Cardiologici Integrati, Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy.
  • Cardiology and Cardiac Rehabilitation Unit, Ospedale Civile, Cecina, Italy.
  • S.C. Cardiologia, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Naples, Italy.
  • Cardiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Zitieren

APA

Canale, M. L., Casolo, G., Donati, S., Bisceglia, I., Puccetti, C., Amoroso, D., Venturini, E., Maurea, N., Turazza, F. M., & Camerini, A. (2023). Baseline Troponin Level and Cardiac Toxicity in HER2-positive Early Breast Cancer Patients Receiving Trastuzumab. In Vivo. https://doi.org/10.21873/invivo.13311

Vancouver

Canale ML, Casolo G, Donati S, Bisceglia I, Puccetti C, Amoroso D, et al. Baseline Troponin Level and Cardiac Toxicity in HER2-positive Early Breast Cancer Patients Receiving Trastuzumab. In Vivo. 2023. doi:10.21873/invivo.13311

BibTeX
@article{Canale2023,
  author = {Canale, Maria Laura and Casolo, Giancarlo and Donati, Sara and Bisceglia, Irma and Puccetti, Cheti and Amoroso, Domenico and Venturini, Elio and Maurea, Nicola and Turazza, Fabio Maria and Camerini, Andrea},
  title = {Baseline Troponin Level and Cardiac Toxicity in HER2-positive Early Breast Cancer Patients Receiving Trastuzumab},
  journal = {In Vivo},
  year = {2023},
  doi = {10.21873/invivo.13311}
}
Kostenlos starten →